Apr 15 |
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
|
Apr 8 |
Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
|
Apr 7 |
Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
|
Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 2 |
Gritstone bio slumps 32%, prices $32.5M equity offering
|
Mar 8 |
Gritstone bio, Inc. (NASDAQ:GRTS) Just Reported And Analysts Have Been Cutting Their Estimates
|
Mar 7 |
Gritstone bio Full Year 2023 Earnings: Beats Expectations
|
Mar 5 |
Gritstone bio GAAP EPS of -$1.20 beats by $0.12, revenue of $16.34M beats by $5.77M
|
Mar 5 |
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
|
Mar 1 |
Why Is Gritstone Bio Stock Trading Lower?
|